Biocon’s stock jumped on December 24 after the United States Food and Drug Administration (USFDA) and the European Union ...

The drug, developed by researchers at Japanese biotech firm Toregem Biopharma, targets a protein in the human body known as ...

Shares of the biopharma major rose earlier today when it announced that its European partner, Zentiva, received a procedure ...

Biocon Ltd is quoting at Rs 352.1, up 1.63% on the day as on 12:49 IST on the NSE. The stock is up 42.35% in last one year as compared to a 9.51% jump in NIFTY and a 36.31% jump in the Nifty Pharma ...

Biocon shares had gained earlier in the day after the company and its European partner Zentiva received a decentralised ...

The European Medicines Agency’s (EMA) Committee for Medicinal Use Products (CHMP) recently recommended approval of six new biosimilars.

The rise in Biocon share price came after it announced that the company and its European partner, Zentiva, have received a ...

BENGALURU: Biocon Biologics, a biosimilars company and subsidiary of Biocon, has announced that the European Medicines Agency ...

Bangalore: Biocon and its European partner, Zentiva, have received a Decentralized Procedure (DCP) approval for its complex ...

Biocon and Zentiva gain EU approval for generic Liraglutide, marking milestone in expanding complex generic medication ...

Biocon Ltd, in collaboration with Zentiva, has obtained EU approval for the complex formulation Liraglutide, a generic ...

Biocon and Zentiva receive EU approval for generic versions of Victoza (diabetes) and Saxenda (weight management). This marks ...